Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumors, Advanced Solid Tumors”

6,269 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,269 results

Early research (Phase 1)Looking for participantsNCT06723236
What this trial is testing

MGC028 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more
MacroGenics 124
Testing effectiveness (Phase 2)Study completedNCT04632992
What this trial is testing

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Who this might be right for
Advanced Unresectable or Metastatic Solid Malignancy
Genentech, Inc. 252
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Early research (Phase 1)Study completedNCT00732992
What this trial is testing

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Who this might be right for
Neoplasm, Malignant
Pfizer 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01058707
What this trial is testing

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid Malignancies
Millennium Pharmaceuticals, Inc. 198
Early research (Phase 1)Study completedNCT00586092
What this trial is testing

A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Herbert Hurwitz 45
Early research (Phase 1)Not Yet RecruitingNCT07836036
What this trial is testing

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

Who this might be right for
Solid TumorRAS Mutation
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 200
Early research (Phase 1)Study completedNCT02564900
What this trial is testing

Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Tumors
Daiichi Sankyo Co., Ltd. 292
Early research (Phase 1)Ended earlyNCT05904236
What this trial is testing

Safety and Tolerability of Intravenous Administration of ICVB-1042

Who this might be right for
Patients With Advanced Solid Tumors
IconOVir Bio 17
Early research (Phase 1)Ended earlyNCT00996892
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Genentech, Inc. 178
Early research (Phase 1)Looking for participantsNCT06598800
What this trial is testing

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 153
Early research (Phase 1)Study completedNCT00316511
What this trial is testing

Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

Who this might be right for
MalignanciesB-Cell Lymphoma
Agenus Inc. 21
Early research (Phase 1)Study completedNCT01195311
What this trial is testing

A Dose-escalation Study in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 52
Early research (Phase 1)Study completedNCT02004717
What this trial is testing

Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Daiichi Sankyo Co., Ltd. 37
Early research (Phase 1)WithdrawnNCT05381935
What this trial is testing

ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
Elpiscience Biopharma, Ltd.
Next Page